SPOTLIGHT: Execs question impact of anti-kickback victories


Recently, the federal government unveiled a $311 million settlement with a bevy of device makers including Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Corp. and Zimmer Holdings. In the settlement, investigators said the firms had provided consulting fees, cash payoffs, trips and other incentives for doctors to use their products. Unfortunately, though, while this looks good on paper, the reality is that the settlement may not do much to address other potentially legal deals which tend to drive up the cost of devices, critics say. Article 

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.